AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 2704576 — intervention group
Group type: EXPERIMENTAL
Intervention: Music intervention
Number of subjects: 58
Study 2704576 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrauterine sounds intervention
Number of subjects: 58
Study 2704576 — intervention group
Group type: COMPARATOR
Intervention: Control (routine care)
Number of subjects: 58
Study 1082238 — intervention group
Group type: EXPERIMENTAL
Intervention: 200,000 IU of vitamin A every 4 months
Number of subjects: 0
Study 1082238 — intervention group
Group type: COMPARATOR
Intervention: Alternate day dose of vitamin A in addition to massive therapy
Number of subjects: 0
Study 30671591 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Running
Number of subjects: 20
Study 30671591 — intervention group
Group type: COMPARATOR
Intervention: High-Intensity Interval Cycling
Number of subjects: 20
Study 29558290 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive psychology intervention
Number of subjects: 50
Study 29558290 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 50
Study 27155753 — intervention group
Group type: EXPERIMENTAL
Intervention: SFC group (25/50 μg b.i.d.)
Number of subjects: 128
Study 27155753 — intervention group
Group type: COMPARATOR
Intervention: FP group (100 μg b.i.d.)
Number of subjects: 128
Study 24481211 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab nasal spray (25 mg/mL) at doses of 12.5, 25, 50, 75, and 100 mg
Number of subjects: 40
Study 24481211 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 22258708 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose of vaccine with 15 μg hemagglutination antigen (HA)
Number of subjects: 218
Study 22258708 — intervention group
Group type: EXPERIMENTAL
Intervention: Two doses of 15 μg HA
Number of subjects: 218
Study 22258708 — intervention group
Group type: EXPERIMENTAL
Intervention: Two doses of 30 μg HA
Number of subjects: 218
Study 22258708 — intervention group
Group type: EXPERIMENTAL
Intervention: Two doses of 15 μg HA for elderly
Number of subjects: 218
Study 22258708 — intervention group
Group type: EXPERIMENTAL
Intervention: Two doses of 30 μg HA for elderly
Number of subjects: 218
Study 20638909 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomiphene citrate
Number of subjects: 70
Study 20638909 — intervention group
Group type: EXPERIMENTAL
Intervention: Ovarian stimulation for IVF
Number of subjects: 70
Study 20638909 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral contraception
Number of subjects: 70
Study 20638909 — intervention group
Group type: EXPERIMENTAL
Intervention: Dehydrogesterone for endometrial luteal phase defect
Number of subjects: 70
Study 20638909 — intervention group
Group type: EXPERIMENTAL
Intervention: Two different regimens of hormone replacement therapy
Number of subjects: 70
Study 20638909 — intervention group
Group type: EXPERIMENTAL
Intervention: No treatment
Number of subjects: 70
Study 20638909 — intervention group
Group type: COMPARATOR
Intervention: Healthy fertile women (control group)
Number of subjects: 70
Study 17998491 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength training, aerobic, and flexibility exercise (ST)
Number of subjects: 207
Study 17998491 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic and flexibility exercise (AE)
Number of subjects: 207
Study 17998491 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibromyalgia Self‐Help Course (FSHC)
Number of subjects: 207
Study 17998491 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of strength training and Fibromyalgia Self‐Help Course (ST-FSHC)
Number of subjects: 207
Study 17998491 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise alone and in combination with education
Number of subjects: 207
Study 17998491 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive walking, simple strength training movements, and stretching activities
Number of subjects: 207
Study 16330790 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (60 units)
Number of subjects: 60
Study 16330790 — intervention group
Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 60
Study 11971633 — intervention group
Group type: EXPERIMENTAL
Intervention: Forward version of liquid pouring from a beaker to a glass
Number of subjects: 7
Study 11971633 — intervention group
Group type: EXPERIMENTAL
Intervention: Forward versions of gravity-related events
Number of subjects: 7
Study 11971633 — intervention group
Group type: EXPERIMENTAL
Intervention: Separation events
Number of subjects: 7
Study 10424549 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioabsorbable interference screws (Bioscrew)
Number of subjects: 204
Study 10424549 — intervention group
Group type: COMPARATOR
Intervention: Metal interference screws
Number of subjects: 204
Study 7489269 — intervention group
Group type: EXPERIMENTAL
Intervention: Polylactic acid granules
Number of subjects: 161
Study 7489269 — intervention group
Group type: COMPARATOR
Intervention: Control (no polylactic acid granules)
Number of subjects: 161
Study 2268533 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent intrathecal methotrexate therapy
Number of subjects: 70
Study 2268533 — intervention group
Group type: COMPARATOR
Intervention: No concurrent intrathecal methotrexate therapy
Number of subjects: 70
Study 367410 — intervention group
Group type: EXPERIMENTAL
Intervention: Labetalol
Number of subjects: 0
Study 367410 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 0
Study 367410 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 30859382 — intervention group
Group type: EXPERIMENTAL
Intervention: Anakinra
Number of subjects: 120
Study 30859382 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab
Number of subjects: 120
Study 30859382 — intervention group
Group type: COMPARATOR
Intervention: Prednisolone
Number of subjects: 120
Study 28779582 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen (HBO₂) treatment
Number of subjects: 28
Study 26228322 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose of cefuroxime sodium and metronidazole half-an-hour before induction (Group A)
Number of subjects: 390
Study 26228322 — intervention group
Group type: COMPARATOR
Intervention: Repeated dose of cefuroxime sodium and metronidazole postoperatively (Group B)
Number of subjects: 390
Study 26228322 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose of cefuroxime sodium and metronidazole (Group A)
Number of subjects: 390
Study 26228322 — intervention group
Group type: COMPARATOR
Intervention: Repeated dose of cefuroxime sodium and metronidazole (Group B)
Number of subjects: 390
Study 23987005 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT)
Number of subjects: 60
Study 23987005 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study 22619107 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained virological response (SVR) after PEG‐IFNα2a/RBV or PEG‐IFNα2b/RBV treatment
Number of subjects: 431
Study 22619107 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment failure (non-SVR)
Number of subjects: 431
Study 19009225 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-day catheter group
Number of subjects: 150
Study 19009225 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-day catheter group
Number of subjects: 150
Study 19009225 — intervention group
Group type: EXPERIMENTAL
Intervention: No catheter use group
Number of subjects: 150
Study 19009225 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term indwelling catheterization
Number of subjects: 150
Study 19009225 — intervention group
Group type: COMPARATOR
Intervention: Overall findings
Number of subjects: 150
Study 17519217 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral psoralen‐UV‐A (PUVA) therapy
Number of subjects: 56
Study 17519217 — intervention group
Group type: COMPARATOR
Intervention: Narrowband-UV-B (NB‐UVB) therapy
Number of subjects: 56
Study 15385346 — intervention group
Group type: EXPERIMENTAL
Intervention: Peripherally inserted central catheters (PICCs)
Number of subjects: 0
Study 15385346 — intervention group
Group type: COMPARATOR
Intervention: Peripheral IV catheter (PIV)
Number of subjects: 0
Study 11379362 — intervention group
Group type: EXPERIMENTAL
Intervention: Eradication treatment (pantoprazole 40 mg once daily, amoxycillin 100 mg b.i.d., clarithromycine 500 mg b.i.d.)
Number of subjects: 251
Study 11379362 — intervention group
Group type: EXPERIMENTAL
Intervention: Eradication treatment
Number of subjects: 251
Study 9685916 — intervention group
Group type: EXPERIMENTAL
Intervention: Soft gelatin capsule containing PEG 400 suspension of gliclazide
Number of subjects: 16
Study 9685916 — intervention group
Group type: COMPARATOR
Intervention: Diamicron (conventional tablet)
Number of subjects: 16
Study 1559090 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate physiotherapy intervention by a physiotherapist
Number of subjects: 94
Study 1559090 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed physiotherapy intervention by a physiotherapist
Number of subjects: 94
Study 1559090 — intervention group
Group type: COMPARATOR
Intervention: Control group (untreated)
Number of subjects: 94
Study 2985658 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril (25 mg tid increased to 100 mg tid)
Number of subjects: 20
Study 2985658 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril (5 mg bid increased to 20 mg bid)
Number of subjects: 20
Study 2985658 — intervention group
Group type: COMPARATOR
Intervention: Methyldopa (250 mg to 500 mg bid and 1,000 mg bid)
Number of subjects: 20
Study 2985658 — intervention group
Group type: COMPARATOR
Intervention: Captopril and Enalapril (both groups)
Number of subjects: 20
Study 30882578 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative Radiation Therapy (PR group) with 150 mg/m/wk intra-arterial cisplatin for 4 weeks followed by radiotherapy
Number of subjects: 998
Study 30882578 — intervention group
Group type: COMPARATOR
Intervention: Definitive Radiation Therapy (DR group) with 150 mg/m/wk intra-arterial cisplatin for 4 weeks followed by definitive radiotherapy
Number of subjects: 998
Study 28597718 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive running working memory training for 20 days
Number of subjects: 54
Study 28597718 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 54
Study 26943871 — intervention group
Group type: EXPERIMENTAL
Intervention: MIS-TLIF
Number of subjects: 97
Study 26943871 — intervention group
Group type: COMPARATOR
Intervention: W-TLIF
Number of subjects: 97
Study 24559178 — intervention group
Group type: EXPERIMENTAL
Intervention: Current Best Practices (CBP)
Number of subjects: 18
Study 24559178 — intervention group
Group type: EXPERIMENTAL
Intervention: Current Best Practices (CBP) + Provider Performance Feedback (PF)
Number of subjects: 18
Study 24559178 — intervention group
Group type: EXPERIMENTAL
Intervention: Current Best Practices (CBP) + Provider Performance Feedback (PF) + Pay-for-Performance (P4P)
Number of subjects: 18
Study 22983924 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate (maximum dose of 75 mg)
Number of subjects: 13
Study 22983924 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 19159901 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombolytic therapy
Number of subjects: 36
Study 19159901 — intervention group
Group type: COMPARATOR
Intervention: No thrombolytic therapy
Number of subjects: 36
Study 19159901 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined groups
Number of subjects: 36
Study 17882542 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative discussions
Number of subjects: 114
Study 17882542 — intervention group
Group type: COMPARATOR
Intervention: Positive interactions
Number of subjects: 114
Study 17882542 — intervention group
Group type: COMPARATOR
Intervention: Neutral interactions
Number of subjects: 114
Study 15036550 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin 600 mg/d
Number of subjects: 7
Study 15036550 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin 1200 mg/d
Number of subjects: 7
Study 15036550 — intervention group
Group type: COMPARATOR
Intervention: Cocaine (0, 12, 25, and 50 mg)
Number of subjects: 7
Study 15036550 — intervention group
Group type: COMPARATOR
Intervention: Gabapentin (0 mg/d)
Number of subjects: 7
Study 11751775 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous infusion (CI) of ceftazidime 1 g iv followed by a 4.5 g CI over 24 h
Number of subjects: 18
Study 11751775 — intervention group
Group type: COMPARATOR
Intervention: 8-hourly administration of ceftazidime 1.5 g tds
Number of subjects: 18
Study 11751775 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous infusion (CI) of ceftazidime
Number of subjects: 18
Study 9664988 — intervention group
Group type: EXPERIMENTAL
Intervention: Internal biliary stent (group I, n=18)
Number of subjects: 37
Study 9664988 — intervention group
Group type: COMPARATOR
Intervention: No internal biliary stent (group II, n=19)
Number of subjects: 37
Study 8540932 — intervention group
Group type: EXPERIMENTAL
Intervention: Ampicillin/sulbactam
Number of subjects: 94
Study 8540932 — intervention group
Group type: COMPARATOR
Intervention: Ampicillin alone
Number of subjects: 94
Study 2365897 — intervention group
Group type: EXPERIMENTAL
Intervention: Multisystemic therapy (MST)
Number of subjects: 61
Study 2365897 — intervention group
Group type: COMPARATOR
Intervention: Individual therapy
Number of subjects: 61
Study 2365897 — intervention group
Group type: COMPARATOR
Intervention: Well-adjusted adolescents
Number of subjects: 61
Study 363333 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol 100 mg twice daily
Number of subjects: 45
Study 363333 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol 100 mg twice daily + Chlorthalidone 50 mg daily
Number of subjects: 45
Study 363333 — intervention group
Group type: COMPARATOR
Intervention: Chlorthalidone 50 mg daily
Number of subjects: 45
Study 31513881 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 seconds hand antisepsis
Number of subjects: 0
Study 31513881 — intervention group
Group type: COMPARATOR
Intervention: 30 seconds hand antisepsis
Number of subjects: 0
Study 30935338 — intervention group
Group type: EXPERIMENTAL
Intervention: UPA lumbar mobilizations
Number of subjects: 24
Study 27757706 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 100
Study 24997025 — intervention group
Group type: EXPERIMENTAL
Intervention: Stainless steel brackets
Number of subjects: 60
Study 24997025 — intervention group
Group type: EXPERIMENTAL
Intervention: Titanium brackets
Number of subjects: 60
Study 24997025 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceramic brackets with metal slots
Number of subjects: 60
Study 24997025 — intervention group
Group type: EXPERIMENTAL
Intervention: Stainless steel retainers
Number of subjects: 60
Study 23685940 — intervention group
Group type: EXPERIMENTAL
Intervention: TVR plus PEG‐IFN‐α2a‐ribavirin
Number of subjects: 62
Study 23685940 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus PEG‐IFN‐α2a‐ribavirin
Number of subjects: 62
Study 22001172 — intervention group
Group type: EXPERIMENTAL
Intervention: VLCD + exercise
Number of subjects: 27
Study 22001172 — intervention group
Group type: COMPARATOR
Intervention: VLCD only
Number of subjects: 27
Study 19778981 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise and education
Number of subjects: 98
Study 19778981 — intervention group
Group type: COMPARATOR
Intervention: Education only
Number of subjects: 98
Study 19778981 — intervention group
Group type: COMPARATOR
Intervention: Usual physical therapy
Number of subjects: 98
Study 16710853 — intervention group
Group type: EXPERIMENTAL
Intervention: OFC (olanzapine/fluoxetine combination)
Number of subjects: 483
Study 16710853 — intervention group
Group type: COMPARATOR
Intervention: Olanzapine
Number of subjects: 483
Study 16710853 — intervention group
Group type: COMPARATOR
Intervention: Fluoxetine
Number of subjects: 483
Study 16710853 — intervention group
Group type: COMPARATOR
Intervention: Venlafaxine
Number of subjects: 483
Study 16710853 — intervention group
Group type: EXPERIMENTAL
Intervention: OFC (at end point)
Number of subjects: 483
Study 16710853 — intervention group
Group type: EXPERIMENTAL
Intervention: OFC (subgroup analysis)
Number of subjects: 483
Study 15261700 — intervention group
Group type: EXPERIMENTAL
Intervention: Real TMS at 1 Hz and 80% of motor threshold over left temporo-parietal cortex
Number of subjects: 16
Study 15261700 — intervention group
Group type: COMPARATOR
Intervention: Sham TMS
Number of subjects: 16
Study 15261700 — intervention group
Group type: EXPERIMENTAL
Intervention: Real TMS
Number of subjects: 16
Study 15261700 — intervention group
Group type: EXPERIMENTAL
Intervention: Second treatments (real or sham)
Number of subjects: 16
Study 12577356 — intervention group
Group type: EXPERIMENTAL
Intervention: Astragalus injection (AI)
Number of subjects: 136
Study 12577356 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 136
Study 12577356 — intervention group
Group type: COMPARATOR
Intervention: Healthy subjects (control group)
Number of subjects: 136
Study 9204358 — intervention group
Group type: EXPERIMENTAL
Intervention: Iopentol (Imagopaque 350 mg I/ml)
Number of subjects: 79
Study 9204358 — intervention group
Group type: COMPARATOR
Intervention: Diatrizoate (Urografin 370 mg I/ml)
Number of subjects: 79
Study 8043624 — intervention group
Group type: EXPERIMENTAL
Intervention: Young adults (mean age = 25.2 years)
Number of subjects: 3
Study 8043624 — intervention group
Group type: EXPERIMENTAL
Intervention: Young-old adults (mean age = 66.0 years)
Number of subjects: 3
Study 8043624 — intervention group
Group type: EXPERIMENTAL
Intervention: Old adults (mean age = 74.7 years)
Number of subjects: 3
Study 2927976 — intervention group
Group type: EXPERIMENTAL
Intervention: Bennett‐Twin nebulizer (output 0.31 ml/min, nebulization time 1 min)
Number of subjects: 32
Study 2927976 — intervention group
Group type: COMPARATOR
Intervention: Wright nebulizer (output 0.15 ml/min, nebulization time 2 min)
Number of subjects: 32
Study 2927976 — intervention group
Group type: EXPERIMENTAL
Intervention: Wright nebulizer driven by a flow rate of 12 L/min (output 0.30 ml/min, nebulization time 1 min)
Number of subjects: 32
Study 2927976 — intervention group
Group type: COMPARATOR
Intervention: Wright nebulizer driven by a flow rate of 7 L/min (output 0.15 ml/min, nebulization time 2 min)
Number of subjects: 32
Study 29294970 — intervention group
Group type: EXPERIMENTAL
Intervention: CA + ICDP + VC
Number of subjects: 176
Study 29294970 — intervention group
Group type: EXPERIMENTAL
Intervention: CA + ICDP
Number of subjects: 176
Study 29294970 — intervention group
Group type: COMPARATOR
Intervention: CA
Number of subjects: 176
Study 31885071 — intervention group
Group type: EXPERIMENTAL
Intervention: RBC transfusion at a Hb threshold of 7 g/dl
Number of subjects: 998
Study 31885071 — intervention group
Group type: COMPARATOR
Intervention: RBC transfusion at a Hb threshold of 9 g/dl
Number of subjects: 998
Study 30908336 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture treatment
Number of subjects: 23138
Study 30908336 — intervention group
Group type: COMPARATOR
Intervention: Sham-acupuncture control
Number of subjects: 23138
Study 30908336 — intervention group
Group type: COMPARATOR
Intervention: Non-acupuncture control
Number of subjects: 23138
Study 28264612 — intervention group
Group type: EXPERIMENTAL
Intervention: Ingenol disoxate 0.018% gel
Number of subjects: 0
Study 28264612 — intervention group
Group type: EXPERIMENTAL
Intervention: Ingenol disoxate 0.012% gel
Number of subjects: 0
Study 28264612 — intervention group
Group type: EXPERIMENTAL
Intervention: Ingenol disoxate 0.006% gel
Number of subjects: 0
Study 28264612 — intervention group
Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 0
Study 26262712 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil plus vitamin E
Number of subjects: 74
Study 26262712 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil
Number of subjects: 74
Study 26262712 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74
Study 23800705 — intervention group
Group type: EXPERIMENTAL
Intervention: Children with ADHD
Number of subjects: 59
Study 23800705 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 59
Study 21806518 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated cognitive behaviour therapy and motivational interviewing (CBT/MI) delivered by a therapist
Number of subjects: 274
Study 21806518 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated CBT/MI delivered by computer (clinician-assisted computerised [CAC] treatment)
Number of subjects: 274
Study 21806518 — intervention group
Group type: COMPARATOR
Intervention: Person-centred therapy (PCT) - control group
Number of subjects: 274
Study 19329193 — intervention group
Group type: EXPERIMENTAL
Intervention: Daytime intravenous glucocorticoid treatment
Number of subjects: 35
Study 19329193 — intervention group
Group type: EXPERIMENTAL
Intervention: Nighttime intravenous glucocorticoid treatment
Number of subjects: 35
Study 19329193 — intervention group
Group type: COMPARATOR
Intervention: Both treatment protocols
Number of subjects: 35
Study 16886837 — intervention group
Group type: EXPERIMENTAL
Intervention: Sarpogrelate 200 mg bid
Number of subjects: 364
Study 16886837 — intervention group
Group type: EXPERIMENTAL
Intervention: Sarpogrelate 200 mg tid
Number of subjects: 364
Study 16886837 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 364
Study 15236142 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized adrenaline (3 mg)
Number of subjects: 38
Study 15236142 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized terbutaline (5 mg)
Number of subjects: 38
Study 11740299 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower body negative pressure (LBNP) from 0 to -60 mm Hg in exercise-trained females (ET)
Number of subjects: 49
Study 11740299 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower body negative pressure (LBNP) in exercise-trained females (ET+syncope)
Number of subjects: 49
Study 11740299 — intervention group
Group type: COMPARATOR
Intervention: Lower body negative pressure (LBNP) in untrained females (UT)
Number of subjects: 49
Study 9413965 — intervention group
Group type: EXPERIMENTAL
Intervention: Colour Doppler ultrasonography
Number of subjects: 113
Study 9413965 — intervention group
Group type: EXPERIMENTAL
Intervention: Spectral Doppler analysis
Number of subjects: 113
Study 9413965 — intervention group
Group type: EXPERIMENTAL
Intervention: Colour Doppler patterns
Number of subjects: 113
Study 9413965 — intervention group
Group type: EXPERIMENTAL
Intervention: Colour Doppler parameters
Number of subjects: 113